Amgen News

TD Cowen: Maintaining the Amgen (AMGN.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $370.00 to $360.00.

Zhitong FinanceApr 17 18:11

Amgen Analyst Ratings

BenzingaApr 17 17:57

TD Cowen Maintains Buy on Amgen, Lowers Price Target to $360

BenzingaApr 17 18:04

Amgen Analyst Ratings

BenzingaApr 12 23:59

Truist Securities: Revised Amgen (AMGN.US) rating and adjusted from buy to buy rating, target price adjusted from $320.00 to $320.00.

Zhitong FinanceApr 13 00:01

Morgan Stanley Cuts Price Target on Amgen to $271 From $278, Keeps Equalweight Rating

MT NewswiresApr 9 20:04

Amgen Analyst Ratings

BenzingaApr 3 20:45

Amgen Analyst Ratings

BenzingaMar 29 01:06

Barclays Sticks to Their Sell Rating for Amgen (AMGN)

TipRanksFeb 23 16:15

Amgen Analyst Ratings

BenzingaFeb 8 23:32

Amgen Stock Downgraded Amid Obesity Drug Uncertainty

InvestingFeb 7 23:58

Amgen Analyst Ratings

BenzingaFeb 7 21:27

Goldman Sachs Adjusts Amgen Price Target to $350 From $313, Maintains Buy Rating

MT NewswiresFeb 7 20:45

RBC Boosts Price Target on Amgen to $329 From $303 After Q4 Beats, Notes 'Positive' Pipeline Posture; Keeps Outperform Rating

MT NewswiresFeb 7 20:11

Deutsche Bank Adjusts Amgen Price Target to $285 From $240, Maintains Hold Rating

MT NewswiresFeb 3 00:16

UBS Maintains Neutral on Amgen, Lowers Price Target to $314

BenzingaJan 30 00:44

Amgen Analyst Ratings

BenzingaJan 30 00:42

RBC Lifts Price Target on Amgen to $303 From $300, Keeps Outperform Rating

MT NewswiresJan 3 21:05

Daiwa Capital Upgrades Amgen to Buy, Announces $320 Price Target

BenzingaDec 21, 2023 19:28

Amgen Analyst Ratings

BenzingaDec 21, 2023 19:27